475 related articles for article (PubMed ID: 21530683)
1. CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis.
Christensen GB; Hvid M; Kvist PH; Deleuran B; Deleuran M; Vestergaard C; Kemp K
Int Immunopharmacol; 2011 Sep; 11(9):1285-92. PubMed ID: 21530683
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system.
Hvid M; Jensen HK; Deleuran B; Kemp K; Andersson C; Deleuran M; Vestergaard C
Int Arch Allergy Immunol; 2009; 149(3):188-94. PubMed ID: 19218811
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic acid attenuates 2,4-dinitrofluorobenzene-induced atopic dermatitis in NC/Nga mice.
Jang AH; Kim TH; Kim GD; Kim JE; Kim HJ; Kim SS; Jin YH; Park YS; Park CS
Int Immunopharmacol; 2011 Sep; 11(9):1271-7. PubMed ID: 21504802
[TBL] [Abstract][Full Text] [Related]
4. Hyperresponsive TH2 cells with enhanced nuclear factor-kappa B activation induce atopic dermatitis-like skin lesions in Nishiki-nezumi Cinnamon/Nagoya mice.
Tenda Y; Yamashita M; Kimura MY; Hasegawa A; Shimizu C; Kitajima M; Onodera A; Suzuki A; Seki N; Nakayama T
J Allergy Clin Immunol; 2006 Sep; 118(3):725-33. PubMed ID: 16950294
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effects of streptococcal preparation OK-432 on atopic dermatitis-like lesions in NC/Nga mice: possible shift from a Th2- to Th1-predominance.
Horiuchi Y; Bae S; Katayama I; Nishioka K
J Dermatol Sci; 2004 Sep; 35(3):187-97. PubMed ID: 15381240
[TBL] [Abstract][Full Text] [Related]
6. Glucosamine improved atopic dermatitis-like skin lesions in NC/Nga mice by inhibition of Th2 cell development.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2011 Jun; 73(6):536-45. PubMed ID: 21284687
[TBL] [Abstract][Full Text] [Related]
7. Essential role of MHC II-independent CD4+ T cells, IL-4 and STAT6 in contact hypersensitivity induced by fluorescein isothiocyanate in the mouse.
Takeshita K; Yamasaki T; Akira S; Gantner F; Bacon KB
Int Immunol; 2004 May; 16(5):685-95. PubMed ID: 15096484
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice.
Kim DY; Jung JA; Kim TH; Seo SW; Jung SK; Park CS
J Ethnopharmacol; 2009 Apr; 122(3):567-72. PubMed ID: 19429328
[TBL] [Abstract][Full Text] [Related]
9. Skin homing (cutaneous lymphocyte-associated antigen-positive) CD8+ T cells respond to superantigen and contribute to eosinophilia and IgE production in atopic dermatitis.
Akdis M; Simon HU; Weigl L; Kreyden O; Blaser K; Akdis CA
J Immunol; 1999 Jul; 163(1):466-75. PubMed ID: 10384150
[TBL] [Abstract][Full Text] [Related]
10. Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance.
Kim CH; Park CD; Lee AY
Vaccine; 2012 Mar; 30(14):2405-10. PubMed ID: 22119586
[TBL] [Abstract][Full Text] [Related]
11. Development of effector CD8+ T cells in contact hypersensitivity occurs independently of CD4+ T cells.
Xu H; Banerjee A; Dilulio NA; Fairchild RL
J Immunol; 1997 May; 158(10):4721-8. PubMed ID: 9144485
[TBL] [Abstract][Full Text] [Related]
12. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
13. Pyridone 6, a pan-JAK inhibitor, ameliorates allergic skin inflammation of NC/Nga mice via suppression of Th2 and enhancement of Th17.
Nakagawa R; Yoshida H; Asakawa M; Tamiya T; Inoue N; Morita R; Inoue H; Nakao A; Yoshimura A
J Immunol; 2011 Nov; 187(9):4611-20. PubMed ID: 21957150
[TBL] [Abstract][Full Text] [Related]
14. Effects of TNCB sensitization in DS-Nh mice, serving as a model of atopic dermatitis, in comparison with NC/Nga mice.
Matsukura S; Aihara M; Hirasawa T; Ikezawa Z
Int Arch Allergy Immunol; 2005 Feb; 136(2):173-80. PubMed ID: 15650316
[TBL] [Abstract][Full Text] [Related]
15. Cytokine production, activation marker, and skin homing receptor in children with atopic dermatitis and bronchial asthma.
Antúnez C; Torres MJ; Mayorga C; Corzo JL; Jurado A; Santamaría-Babi LF; Vera A; Blanca M
Pediatr Allergy Immunol; 2006 May; 17(3):166-74. PubMed ID: 16672002
[TBL] [Abstract][Full Text] [Related]
16. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effects of combination using glucosamine plus tacrolimus (FK-506) on the development of atopic dermatitis-like skin lesions in NC/Nga mice.
Kim CH; Cheong KA; Park CD; Lee AY
Scand J Immunol; 2012 May; 75(5):471-8. PubMed ID: 22023698
[TBL] [Abstract][Full Text] [Related]
18. Different cytokine production and activation marker profiles in circulating cutaneous-lymphocyte-associated antigen T cells from patients with acute or chronic atopic dermatitis.
Antúnez C; Torres MJ; Mayorga C; Cornejo-García JA; Santamaría-Babi LF; Blanca M
Clin Exp Allergy; 2004 Apr; 34(4):559-66. PubMed ID: 15080808
[TBL] [Abstract][Full Text] [Related]
19. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
Bovenschen HJ; Seyger MM; Van de Kerkhof PC
Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor, trichostatin A, inhibits the development of 2,4-dinitrofluorobenzene-induced dermatitis in NC/Nga mice.
Kim TH; Jung JA; Kim GD; Jang AH; Cho JJ; Park YS; Park CS
Int Immunopharmacol; 2010 Oct; 10(10):1310-5. PubMed ID: 20728595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
